Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2010 Feb 1;20(2):93–105. doi: 10.1002/rmv.638

Viral infections associated with haemophagocytic syndrome

Nadine Rouphael Maakaroun 1,†,✉, Abeer Moanna 2,†, Jesse T Jacob 1,†, Helmut Albrecht 3,‡
PMCID: PMC7169125  PMID: 20127750

Abstract

Haemophagocytic syndrome (HPS) or haemophagocytic lymphohistiocytosis (HLH) is a rare disease caused by a dysfunction of cytotoxic T cells and NK cells. This T cell/NK cell dysregulation causes an aberrant cytokine release, resulting in proliferation/activation of histiocytes with subsequent haemophagocytosis. Histiocytic infiltration of the reticuloendothelial system results in hepatomegaly, splenomegaly, lymphadenopathy and pancytopenia ultimately leading to multiple organ dysfunctions. Common clinical features include high fevers despite broad spectrum antimicrobials, maculopapular rash, neurological symptoms, coagulopathy and abnormal liver function tests. Haemophagocytic syndrome can be either primary, i.e. due to an underlying genetic defect or secondary, associated with malignancies, autoimmune diseases (also called macrophage activation syndrome) or infections. Infectious triggers are most commonly due to viral infections mainly of the herpes group, with EBV being the most common cause. HPS can be fatal if untreated. Early recognition of the clinical presentation and laboratory abnormalities associated with HPS and prompt initiation of treatment can be life saving. HPS triggered by viral infections generally does not respond to specific antiviral therapy but may be treated with immunosuppressive/immunomodulatory agents and, in refractory cases, with bone marrow transplantation. Copyright © 2010 John Wiley & Sons, Ltd.

REFERENCES

  • 1. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007; 7: 814–822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Scott R, Robb‐Smith A. Histiocytic medullary reticulosis. Lancet 1939; 2: 194–198. [Google Scholar]
  • 3. Risdall RJ, McKenna RW, Nesbit ME, et al Virus‐associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993–1002. [DOI] [PubMed] [Google Scholar]
  • 4. Ishii E, Ohga S, Imashuku S, et al Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007; 86: 58–65. [DOI] [PubMed] [Google Scholar]
  • 5. Allen M, De Fusco C, Legrand F, et al Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica 2001; 86: 499–503. [PubMed] [Google Scholar]
  • 6. Henter JI, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993; 82: 369–372. [DOI] [PubMed] [Google Scholar]
  • 7. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 2006; 38: 20–31. [DOI] [PubMed] [Google Scholar]
  • 8. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child 1952; 27: 519–525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991; 80: 428–435. [DOI] [PubMed] [Google Scholar]
  • 10. Ishii E, Ohga S, Tanimura M, et al Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group. Med Pediatr Oncol 1998; 30: 276–283. [DOI] [PubMed] [Google Scholar]
  • 11. Dhote R, Simon J, Papo T, et al Reactive hemophagocytic syndrome in adult systemic disease: report of twenty‐six cases and literature review. Arthritis Rheum 2003; 49: 633–639. [DOI] [PubMed] [Google Scholar]
  • 12. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection‐ and malignancy‐associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435–444. [DOI] [PubMed] [Google Scholar]
  • 13. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6: 601–608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. de Saint Basile G, Fischer A. Defective cytotoxic granule‐mediated cell death pathway impairs T lymphocyte homeostasis. Curr Opin Rheumatol 2003; 15: 436–445. [DOI] [PubMed] [Google Scholar]
  • 15. Stepp SE, Dufourcq‐Lagelouse R, Le Deist F, et al Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957–1959. [PubMed] [Google Scholar]
  • 16. Fadeel B, Orrenius S, Henter JI. Familial hemophagocytic lymphohistiocytosis: too little cell death can seriously damage your health. Leuk Lymphoma 2001; 42: 13–20. [DOI] [PubMed] [Google Scholar]
  • 17. Ohga S, Matsuzaki A, Nishizaki M, et al Inflammatory cytokines in virus‐associated hemophagocytic syndrome. Interferon‐gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol 1993; 15: 291–298. [PubMed] [Google Scholar]
  • 18. Osugi Y, Hara J, Tagawa S, et al Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100–4103. [PubMed] [Google Scholar]
  • 19. Imashuku S, Hibi S, Fujiwara F, Todo S. Hyper‐interleukin (IL)‐6‐naemia in haemophagocytic lymphohistiocytosis. Br J Haematol 1996; 93: 803–807. [DOI] [PubMed] [Google Scholar]
  • 20. Takada H, Ohga S, Mizuno Y, Nomura A, Hara T. Increased IL‐16 levels in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2004; 26: 567–573. [DOI] [PubMed] [Google Scholar]
  • 21. Takada H, Nomura A, Ohga S, Hara T. Interleukin‐18 in hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2001; 42: 21–28. [DOI] [PubMed] [Google Scholar]
  • 22. Tang Y, Xu X, Song H, et al Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome. Br J Haematol 2008; 143: 84–91. [DOI] [PubMed] [Google Scholar]
  • 23. Komp DM, Buckley PJ, McNamara J, van Hoff J. Soluble interleukin‐2 receptor in hemophagocytic histiocytoses: searching for markers of disease activity. Pediatr Hematol Oncol 1989; 6: 253–264. [DOI] [PubMed] [Google Scholar]
  • 24. Imashuku S, Hibi S, Sako M, et al Soluble interleukin‐2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 1995; 86: 4706–4707. [PubMed] [Google Scholar]
  • 25. Chang YH, Lee DS, Jo HS, et al Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 2006; 36: 45–50. [DOI] [PubMed] [Google Scholar]
  • 26. Kereveur A, McIlroy D, Samri A, Oksenhendler E, Clauvel JP, Autran B. Up‐regulation of adhesion and MHC molecules on splenic monocyte/macrophages in adult haemophagocytic syndrome. Br J Haematol 1999; 104: 871–877. [DOI] [PubMed] [Google Scholar]
  • 27. Emminger W, Zlabinger GJ, Fritsch G, Urbanek R. CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis. Eur J Immunol 2001; 31: 1716–1719. [DOI] [PubMed] [Google Scholar]
  • 28. de Saint Basile G, Fischer A. The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol 2001; 13: 549–554. [DOI] [PubMed] [Google Scholar]
  • 29. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29–33. [PubMed] [Google Scholar]
  • 30. Tokuyasu K, Hara Y, Matsumoto Y, et al Hypertrophic cardiomyopathy with mid‐ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report. J Cardiol 1999; 34: 273–277. [PubMed] [Google Scholar]
  • 31. de Kerguenec C, Hillaire S, Molinie V, et al Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 2001; 96: 852–857. [DOI] [PubMed] [Google Scholar]
  • 32. Okamoto M, Yamaguchi H, Isobe Y, et al Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med 2009; 48: 775–781. [DOI] [PubMed] [Google Scholar]
  • 33. Koduri PR, Carandang G, DeMarais P, Patel AR. Hyperferritinemia in reactive hemophagocytic syndrome report of four adult cases. Am J Hematol 1995; 49: 247–249. [DOI] [PubMed] [Google Scholar]
  • 34. Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008; 50: 1227–1235. [DOI] [PubMed] [Google Scholar]
  • 35. Henter JI, Arico M, Egeler RM, et al HLH‐94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997; 28: 342–347. [DOI] [PubMed] [Google Scholar]
  • 36. Henter JI, Samuelsson‐Horne A, Arico M, et al Treatment of hemophagocytic lymphohistiocytosis with HLH‐94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367–2373. [DOI] [PubMed] [Google Scholar]
  • 37. Imashuku S, Hibi S, Ohara T, et al Effective control of Epstein‐Barr virus‐related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 1999; 93: 1869–1874. [PubMed] [Google Scholar]
  • 38. Imashuku S, Kuriyama K, Teramura T, et al Requirement for etoposide in the treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19: 2665–2673. [DOI] [PubMed] [Google Scholar]
  • 39. Imashuku S, Kuriyama K, Sakai R, et al Treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 2003; 41: 103–109. [DOI] [PubMed] [Google Scholar]
  • 40. Oyama Y, Amano T, Hirakawa S, Hironaka K, Suzuki S, Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder? Br J Haematol 1989; 73: 276–278. [DOI] [PubMed] [Google Scholar]
  • 41. Nagasawa M, Okawa H, Yata J. Deleterious effects of high dose gamma‐globulin therapy on patients with hemophagocytic syndrome. Int J Hematol 1994; 60: 91–93. [PubMed] [Google Scholar]
  • 42. Wang S, Degar BA, Zieske A, Shafi NQ, Rose MG. Hemophagocytosis exacerbated by G‐CSF/GM‐CSF treatment in a patient with myelodysplasia. Am J Hematol 2004; 77: 391–316. [DOI] [PubMed] [Google Scholar]
  • 43. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221–230. [DOI] [PubMed] [Google Scholar]
  • 44. Horne A, Janka G, Maarten Egeler R, et al Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622–630. [DOI] [PubMed] [Google Scholar]
  • 45. Arico M, Janka G, Fischer A, et al Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996; 10: 197–203. [PubMed] [Google Scholar]
  • 46. Chen CJ, Huang YC, Jaing TH, et al Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect 2004; 37: 157–163. [PubMed] [Google Scholar]
  • 47. Imashuku S. Clinical features and treatment strategies of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44: 259–272. [DOI] [PubMed] [Google Scholar]
  • 48. Tabata YS, Teramura T, Kuriyama K, et al Molecular analysis of latent membrane protein 1 in patients with Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis in Japan. Leuk Lymphoma 2000; 38: 373–380. [DOI] [PubMed] [Google Scholar]
  • 49. Elazary AS, Wolf DG, Amir G, et al Severe Epstein‐Barr virus‐associated hemophagocytic syndrome in six adult patients. J Clin Virol 2007; 40: 156–159. [DOI] [PubMed] [Google Scholar]
  • 50. Sonke GS, Ludwig I, van Oosten H, et al Poor outcomes of chronic active Epstein‐Barr virus infection and hemophagocytic lymphohistiocytosis in non‐Japanese adult patients. Clin Infect Dis 2008; 47: 105–108. [DOI] [PubMed] [Google Scholar]
  • 51. Beutel K, Gross‐Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ. Infection of T lymphocytes in Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis in children of non‐Asian origin. Pediatr Blood Cancer 2009; 53: 184–190. [DOI] [PubMed] [Google Scholar]
  • 52. Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M. Fulminant course of infectious mononucleosis with virus‐associated hemophagocytic syndrome. Scand J Infect Dis 1987; 19: 373–379. [DOI] [PubMed] [Google Scholar]
  • 53. Kasahara Y, Yachie A. Cell type specific infection of Epstein‐Barr virus (EBV) in EBV‐associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 2002; 44: 283–94. [DOI] [PubMed] [Google Scholar]
  • 54. Ohshima K, Suzumiya J, Sugihara M, Nagafuchi S, Ohga S, Kikuchi M. Clinicopathological study of severe chronic active Epstein‐Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol Int 1998; 48: 934–943. [DOI] [PubMed] [Google Scholar]
  • 55. Lindemann TL, Greene JS. Persistent cervical lymphadenopathy in an adolescent with Epstein‐Barr induced hemophagocytic syndrome: manifestations of a rare but often fatal disease. Int J Pediatr Otorhinolaryngol 2005; 69: 1011–1014. [DOI] [PubMed] [Google Scholar]
  • 56. Akashi K, Mizuno S. Epstein‐Barr virus‐infected natural killer cell leukemia. Leuk Lymphoma 2000; 40: 57–66. [DOI] [PubMed] [Google Scholar]
  • 57. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Epstein‐Barr virus‐associated T‐lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma 1995; 19: 401–406. [DOI] [PubMed] [Google Scholar]
  • 58. Wada T, Kurokawa T, Toma T, et al Immunophenotypic analysis of Epstein‐Barr virus (EBV)‐infected CD8(+) T cells in a patient with EBV‐associated hemophagocytic lymphohistiocytosis. Eur J Haematol 2007; 79: 72–75. [DOI] [PubMed] [Google Scholar]
  • 59. Chuang HC, Lay JD, Hsieh WC, et al Epstein‐Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 2005; 106: 3090–3096. [DOI] [PubMed] [Google Scholar]
  • 60. Imashuku S, Hibi S, Tabata Y, et al Biomarker and morphological characteristics of Epstein‐Barr virus‐related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1998; 31: 131–137. [DOI] [PubMed] [Google Scholar]
  • 61. Morra M, Howie D, Grande MS, et al X‐linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol 2001; 19: 657–682. [DOI] [PubMed] [Google Scholar]
  • 62. Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein‐Barr virus (EBV) load: the significance and application for each EBV‐associated disease. Rev Med Virol 2008; 18: 305–319. [DOI] [PubMed] [Google Scholar]
  • 63. Kimura H, Nishikawa K, Hoshino Y, Sofue A, Nishiyama Y, Morishima T. Monitoring of cell‐free viral DNA in primary Epstein‐Barr virus infection. Med Microbiol Immunol (Berl) 2000; 188: 197–202. [DOI] [PubMed] [Google Scholar]
  • 64. Kimura H, Hoshino Y, Hara S, et al Viral load in Epstein‐Barr virus‐associated hemophagocytic syndrome. Microbiol Immunol 2002; 46: 579–582. [DOI] [PubMed] [Google Scholar]
  • 65. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku S. Quantitative analysis of cell‐free Epstein‐Barr virus genome copy number in patients with EBV‐associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2002; 43: 173–179. [DOI] [PubMed] [Google Scholar]
  • 66. Bakhshi S, Pautu JL. EBV associated hemophagocytic lymphohistiocytosis with spontaneous regression. Indian Pediatr 2005; 42: 1253–1255. [PubMed] [Google Scholar]
  • 67. Imashuku S, Tabata Y, Teramura T, Hibi S. Treatment strategies for Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH). Leuk Lymphoma 2000; 39: 37–49. [DOI] [PubMed] [Google Scholar]
  • 68. Kaito K, Otsubo H, Takei Y, Usui N, Kobayashi M. Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome. Ann Hematol 2003; 82: 699–701. [DOI] [PubMed] [Google Scholar]
  • 69. Imashuku S, Obayashi M, Hosoi G, et al Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B‐cell depletion and therapeutic results. Br J Haematol 2000; 108: 505–510. [DOI] [PubMed] [Google Scholar]
  • 70. Matsumoto Y, Naniwa D, Banno S, Sugiura Y. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports. Ther Apher 1998; 2: 300–304. [DOI] [PubMed] [Google Scholar]
  • 71. Connolly AA, Rowe‐Jones J, Leighton SE, Ball SE, Davies EG, Moore‐Gillon V. Pseudomonal supraglottitis occurring in a patient with profound neutropenia secondary to virus‐associated haemophagocytic syndrome. J Laryngol Otol 1992; 106: 739–740. [DOI] [PubMed] [Google Scholar]
  • 72. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus‐associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2007; 29: 569–573. [DOI] [PubMed] [Google Scholar]
  • 73. Kaza U, Knight AK, Jeroudi M, Bocchini JA, Jr. , Anga A, Bahna SL. A boy with fever, lymphadenopathy, hepatosplenomegaly, and lymphocytosis. Allergy Asthma Proc 2008; 29: 216–20. [DOI] [PubMed] [Google Scholar]
  • 74. Imashuku S, Hibi S, Todo S, et al Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999; 23: 569–572. [DOI] [PubMed] [Google Scholar]
  • 75. Imashuku S, Teramura T, Tauchi H, et al Longitudinal follow‐up of patients with Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis. Haematologica 2004; 89: 183–188. [PubMed] [Google Scholar]
  • 76. Danish EH, Dahms BB, Kumar ML. Cytomegalovirus‐associated hemophagocytic syndrome. Pediatrics 1985; 75: 280–283. [PubMed] [Google Scholar]
  • 77. Oloomi Z, Moayeri H. Cytomegalovirus infection‐associated hemophagocytic syndrome. Arch Iran Med 2006; 9: 284–287. [PubMed] [Google Scholar]
  • 78. Maruyama K, Koizumi T, Hirato J. Cytomegalovirus infections associated hemophagocytic lymphohistiocytosis in a premature infant. Pediatr Int 2006; 48: 648–650. [DOI] [PubMed] [Google Scholar]
  • 79. Kohara MM, Blum RN. Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti‐tumor necrosis factor‐alpha antibody. Clin Infect Dis 2006; 42: 733–734. [DOI] [PubMed] [Google Scholar]
  • 80. Koketsu S, Watanabe T, Hori N, Umetani N, Takazawa Y, Nagawa H. Hemophagocytic syndrome caused by fulminant ulcerative colitis and cytomegalovirus infection: report of a case. Dis Colon Rectum 2004; 47: 1250–1253; discussion 3–5. [DOI] [PubMed] [Google Scholar]
  • 81. Amenomori M, Migita K, Miyashita T, et al Cytomegalovirus‐associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol 2005; 23: 100–102. [PubMed] [Google Scholar]
  • 82. Sakamoto O, Ando M, Yoshimatsu S, Kohrogi H, Suga M, Ando M. Systemic lupus erythematosus complicated by cytomegalovirus‐induced hemophagocytic syndrome and colitis. Intern Med 2002; 41: 151–155. [DOI] [PubMed] [Google Scholar]
  • 83. Devecioglu O, Anak S, Atay D, et al Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2009; 53: 491–492. [DOI] [PubMed] [Google Scholar]
  • 84. Sato M, Matsushima T, Takada S, et al Fulminant, CMV‐associated, haemophagocytic syndrome following unrelated bone marrow transplantation. Bone Marrow Transplant 1998; 22: 1219–1222. [DOI] [PubMed] [Google Scholar]
  • 85. Hardikar W, Pang K, Al‐Hebbi H, Curtis N, Couper R. Successful treatment of cytomegalovirus‐associated haemophagocytic syndrome following paediatric orthotopic liver transplantation. J Paediatr Child Health 2006; 42: 389–391. [DOI] [PubMed] [Google Scholar]
  • 86. Abdelkefi A, Ben Jamil W, Torjman L, et al Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study. Int J Hematol 2009; 89: 368–373. [DOI] [PubMed] [Google Scholar]
  • 87. Imashuku S, Ueda I, Teramura T, et al Occurrence of haemophagocytic lymphohistiocytosis at less than 1 year of age: analysis of 96 patients. Eur J Pediatr 2005; 164: 315–319. [DOI] [PubMed] [Google Scholar]
  • 88. Uneda S, Murata S, Sonoki T, Matsuoka H, Nakakuma H. Successful treatment with liposomal doxorubicin for widespread Kaposi's sarcoma and human herpesvirus‐8 related severe hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome. Int J Hematol 2009; 89: 195–200. [DOI] [PubMed] [Google Scholar]
  • 89. Stebbing J, Ngan S, Ibrahim H, et al The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus‐associated multi‐centric Castleman's disease. Clin Exp Immunol 2008; 154: 399–405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Pastore RD, Chadburn A, Kripas C, Schattner EJ. Novel association of haemophagocytic syndrome with Kaposi's sarcoma‐associated herpesvirus‐related primary effusion lymphoma. Br J Haematol 2000; 111: 1112–1115. [DOI] [PubMed] [Google Scholar]
  • 91. Fardet L, Blum L, Kerob D, et al Human herpesvirus 8‐associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus‐infected patients. Clin Infect Dis 2003; 37: 285–291. [DOI] [PubMed] [Google Scholar]
  • 92. Bossini N, Sandrini S, Setti G, et al Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8‐related, serious hemophagocytic syndrome, after renal transplantation. G Ital Nefrol 2005; 22: 281–286. [PubMed] [Google Scholar]
  • 93. Re A, Facchetti F, Borlenghi E, et al Fatal hemophagocytic syndrome related to active human herpesvirus‐8/Kaposi sarcoma‐associated herpesvirus infection in human immunodeficiency virus‐negative, non‐transplant patients without related malignancies. Eur J Haematol 2007; 78: 361–364. [DOI] [PubMed] [Google Scholar]
  • 94. Grossman WJ, Radhi M, Schauer D, Gerday E, Grose C, Goldman FD. Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV‐8. Blood 2005; 106: 1203–1206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Corbellino M, Bestetti G, Scalamogna C, et al Long‐term remission of Kaposi sarcoma‐associated herpesvirus‐related multicentric Castleman disease with anti‐CD20 monoclonal antibody therapy. Blood 2001; 98: 3473–3475. [DOI] [PubMed] [Google Scholar]
  • 96. Yamada K, Yamamoto Y, Uchiyama A, et al Successful treatment of neonatal herpes simplex‐type 1 infection complicated by hemophagocytic lymphohistiocytosis and acute liver failure. Tohoku J Exp Med 2008; 214: 1–5. [DOI] [PubMed] [Google Scholar]
  • 97. Ramasamy K, Lim ZY, Savvas M, et al Disseminated herpes virus (HSV‐2) infection with rhabdomyolysis and hemophagocytic lymphohistiocytosis in a patient with bone marrow failure syndrome. Ann Hematol 2006; 85: 629–630. [DOI] [PubMed] [Google Scholar]
  • 98. van der Werff Ten Bosch JE, Kollen WJ, Ball LM, et al Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2009; 53: 226–228. [DOI] [PubMed] [Google Scholar]
  • 99. Tanaka H, Nishimura T, Hakui M, Sugimoto H, Tanaka‐Taya K, Yamanishi K. Human herpesvirus 6‐associated hemophagocytic syndrome in a healthy adult. Emerg Infect Dis 2002; 8: 87–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Doyle T, Bhagani S, Cwynarski K. Haemophagocytic syndrome and HIV. Curr Opin Infect Dis 2009; 22: 1–6. [DOI] [PubMed] [Google Scholar]
  • 101. Albrecht H, Schafer H, Stellbrink HJ, Greten H. Epstein‐Barr virus–Associated hemophagocytic syndrome. A cause of fever of unknown origin in human immunodeficiency virus infection. Arch Pathol Lab Med 1997; 121: 853–858. [PubMed] [Google Scholar]
  • 102. Niedt GW, Schinella RA. Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch Pathol Lab Med 1985; 109: 727–734. [PubMed] [Google Scholar]
  • 103. Sun HY, Chen MY, Fang CT, Hsieh SM, Hung CC, Chang SC. Hemophagocytic lymphohistiocytosis: an unusual initial presentation of acute HIV infection. J Acquir Immune Defic Syndr 2004; 37: 1539–1540. [DOI] [PubMed] [Google Scholar]
  • 104. Castilletti C, Preziosi R, Bernardini G, et al Hemophagocytic syndrome in a patient with acute human immunodeficiency virus infection. Clin Infect Dis 2004; 38: 1792–1793. [DOI] [PubMed] [Google Scholar]
  • 105. Park KH, Yu HS, Jung SI, Shin DH, Shin JH. Acute human immunodeficiency virus syndrome presenting with hemophagocytic lymphohistiocytosis. Yonsei Med J 2008; 49: 325–328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Bhatia S, Bauer F, Bilgrami SA. Candidiasis‐associated hemophagocytic lymphohistiocytosis in a patient infected with human immunodeficiency virus. Clin Infect Dis 2003; 37: e161–e166. [DOI] [PubMed] [Google Scholar]
  • 107. Gotoh M, Matsuda J, Gohchi K, Sanaka T, Kawasugi K. Successful recovery from human immunodeficiency virus (HIV)‐associated haemophagocytic syndrome treated with highly active anti‐retroviral therapy in a patient with HIV infection. Br J Haematol 2001; 112: 1090. [DOI] [PubMed] [Google Scholar]
  • 108. Huang DB, Wu JJ, Hamill RJ. Reactive hemophagocytosis associated with the initiation of highly active antiretroviral therapy (HAART) in a patient with AIDS. Scand J Infect Dis 2004; 36: 516–519. [DOI] [PubMed] [Google Scholar]
  • 109. Cuttelod M, Pascual A, Baur Chaubert AS, et al Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life‐threatening event related to immune restoration inflammatory syndrome? AIDS 2008; 22: 549–551. [DOI] [PubMed] [Google Scholar]
  • 110. De Lavaissiere M, Manceron V, Bouree P, et al Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection. J Infect 2009; 58: 245–247. [DOI] [PubMed] [Google Scholar]
  • 111. Potter MN, Foot AB, Oakhill A. Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia. J Clin Pathol 1991; 44: 297–299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997; 66: 135–151. [DOI] [PubMed] [Google Scholar]
  • 113. Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2000; 21: 449–454. [DOI] [PubMed] [Google Scholar]
  • 114. Ando M, Miyazaki E, Hiroshige S, et al Virus associated hemophagocytic syndrome accompanied by acute respiratory failure caused by influenza A (H3N2). Intern Med 2006; 45: 1183–1186. [DOI] [PubMed] [Google Scholar]
  • 115. Watanabe T, Okazaki E, Shibuya H. Influenza A virus‐associated encephalopathy with haemophagocytic syndrome. Eur J Pediatr 2003; 162: 799–800. [DOI] [PubMed] [Google Scholar]
  • 116. Mou SS, Nakagawa TA, Riemer EC, McLean TW, Hines MH, Shetty AK. Hemophagocytic lymphohistiocytosis complicating influenza a infection. Pediatrics 2006; 118: e216–e219. [DOI] [PubMed] [Google Scholar]
  • 117. Samransamruajkit R, Hiranrat T, Chieochansin T, et al Prevalence, clinical presentations and complications among hospitalized children with influenza pneumonia. Jpn J Infect Dis 2008; 61: 446–449. [PubMed] [Google Scholar]
  • 118. To KF, Chan PK, Chan KF, et al Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63: 242–246. [DOI] [PubMed] [Google Scholar]
  • 119. Zhang Z, Zhang J, Huang K, et al Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum Pathol 2009; 40: 735–739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Kimura K, Adlakha A, Simon PM. Fatal case of swine influenza virus in an immunocompetent host. Mayo Clin Proc 1998; 73: 243–245. [DOI] [PubMed] [Google Scholar]
  • 121. de Jong MD, Bach VC, Phan TQ, et al Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352: 686–691. [DOI] [PubMed] [Google Scholar]
  • 122. Chokephaibulkit K, Uiprasertkul M, Puthavathana P, et al A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J 2005; 24: 162–166. [DOI] [PubMed] [Google Scholar]
  • 123. Peiris JS, Yu WC, Leung CW, et al Re‐emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363: 617–619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Cheung CY, Poon LL, Lau AS, et al Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360: 1831–1817. [DOI] [PubMed] [Google Scholar]
  • 125. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002; 34(Suppl. 2): S58–S64. [DOI] [PubMed] [Google Scholar]
  • 126. Ng WF, To KF, Lam WW, Ng TK, Lee KC. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1–a review. Hum Pathol 2006; 37: 381–390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Hsieh SM, Chang SC. Insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol 2006; 176: 4530–4533. [DOI] [PubMed] [Google Scholar]
  • 128. Cheung CL, Rayner JM, Smith GJ, et al Distribution of amantadine‐resistant H5N1 avian influenza variants in Asia. J Infect Dis 2006; 193: 1626–1629. [DOI] [PubMed] [Google Scholar]
  • 129. Ilyushina NA, Govorkova EA, Webster RG. Detection of amantadine‐resistant variants among avian influenza viruses isolated in North America and Asia. Virology 2005; 341: 102–106. [DOI] [PubMed] [Google Scholar]
  • 130. Le QM, Kiso M, Someya K, et al Avian flu: isolation of drug‐resistant H5N1 virus. Nature 2005; 437: 1108. [DOI] [PubMed] [Google Scholar]
  • 131. de Jong MD, Tran TT, Truong HK, et al Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353: 2667–2672. [DOI] [PubMed] [Google Scholar]
  • 132. Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet 2006; 367: 870–873. [DOI] [PubMed] [Google Scholar]
  • 133. Hermann J, Steinbach D, Lengemann J, Zintl F. Parvovirus B 19 associated hemophagocytic syndrome in a patient with hereditary sperocytosis. Klin Padiatr 2003; 215: 270–274. [DOI] [PubMed] [Google Scholar]
  • 134. Kaya Z, Ozturk G, Gursel T, Bozdayi G. Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with parvovirus b19 infection in a previously healthy child. Jpn J Infect Dis 2005; 58: 149–151. [PubMed] [Google Scholar]
  • 135. Yilmaz S, Oren H, Demircioglu F, Firinci F, Korkmaz A, Irken G. Parvovirus B19: A cause for aplastic crisis and hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2006; 47: 8610. [DOI] [PubMed] [Google Scholar]
  • 136. Larroche C, Scieux C, Honderlick P, Piette AM, Morinet F, Bletry O. Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein‐Barr virus reactivation in an otherwise healthy adult. Eur J Clin Microbiol Infect Dis 2002; 21: 739–742. [DOI] [PubMed] [Google Scholar]
  • 137. Dutta U, Mittal S, Ratho RK, Das A. Acute liver failure and severe hemophagocytosis secondary to parvovirus B19 infection. Indian J Gastroenterol 2005; 24: 118–119. [PubMed] [Google Scholar]
  • 138. Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am J Transplant 2008; 8: 1340–1344. [DOI] [PubMed] [Google Scholar]
  • 139. Miyakawa K, Ohsugi K, Sugahara S, Kuriyama C, Kikuchi A, Ohta M. Tsutsugamushi disease with hemophagocytosis complicated by Parvovirus B19 infection. Nippon Naika Gakkai Zasshi 2006; 95: 2544–2546. [DOI] [PubMed] [Google Scholar]
  • 140. Watanabe M, Shibuya A, Okuno J, Maeda T, Tamama S, Saigenji K. Hepatitis A virus infection associated with hemophagocytic syndrome: report of two cases. Intern Med 2002; 41: 1188–1192. [DOI] [PubMed] [Google Scholar]
  • 141. Tuon FF, Gomes VS, Amato VS, et al Hemophagocytic syndrome associated with hepatitis A: case report and literature review. Rev Inst Med Trop Sao Paulo 2008; 50: 123–127. [DOI] [PubMed] [Google Scholar]
  • 142. Russo RA, Rosenzweig SD, Katsicas MM. Hepatitis A‐associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: report of 2 cases. J Rheumatol 2008; 35: 166–168. [PubMed] [Google Scholar]
  • 143. Katsibardi K, Moschovi MA, Theodoridou M, et al Enterovirus‐associated hemophagocytic syndrome in children with malignancy: report of three cases and review of the literature. Eur J Pediatr 2008; 167: 97–102. [DOI] [PubMed] [Google Scholar]

Articles from Reviews in Medical Virology are provided here courtesy of Wiley

RESOURCES